CATALYST CLINICAL RESEARCH EUROPE, LTD.

Company number 08872035

0 active persons with significant control / 1 active statement

Statement (Active)

• Notified on: 23 August 2023

Catalyst Clinical Research, Llc (Ceased)

• Correspondence address: 2528 Independence Blvd, Suite 100, Wilmington, Nc, United States, 28412
• Notified on: 29 April 2022
• Ceased on: 22 September 2022
• Governing law: Under The Laws Of The State Of North Carolina
• Legal form: Limited Liability Company
• Place registered: Nc Secretary Of State
• Registration number: 1376420
• Incorporated in: United States
• Nature of control: Ownership of shares – 75% or more
• Nature of control: Ownership of voting rights - More than 50% but less than 75%
• Nature of control: Has significant influence or control as a member of a firm

Project Constellation Holdings, Inc. (Ceased)

• Correspondence address: 2528 Independence Blvd, Suite 100, Wilmington, Nc, United States, 28412
• Notified on: 29 April 2022
• Ceased on: 12 September 2022
• Governing law: Under The Laws Of The State Of North Carolina
• Legal form: Legal Corporation
• Place registered: Nc Secretary Of State
• Registration number: 1763160
• Incorporated in: United States
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%

Mr Jonathan Lewis (Ceased)

• Correspondence address: Biohub Alderley Park, Alderley Edge, Macclesfield, Cheshire, United Kingdom, SK10 4TG
• Notified on: 6 April 2016
• Ceased on: 29 April 2022
• Date of birth: May 1962
• Nationality: British
• Country of residence: England
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%

Mr Stephen Mcconchie (Ceased)

• Correspondence address: Biohub Alderley Park, Alderley Edge, Macclesfield, Cheshire, United Kingdom, SK10 4TG
• Notified on: 6 April 2016
• Ceased on: 29 April 2022
• Date of birth: February 1964
• Nationality: British
• Country of residence: United Kingdom
• Nature of control: Ownership of shares – More than 25% but not more than 50%
• Nature of control: Ownership of voting rights - More than 25% but not more than 50%